Michael L Mallory - JoVE Visualize

Showing results (31-40 of 44) with videos related to

Pageof 5

Sort By:

Cell Reports|October 20, 2023

Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Tyler D Gavitt, et al.

Emerging Infectious Diseases|December 8, 2023

Emergence of Novel Norovirus GII.4 VariantPreeti Chhabra, Damien C Tully, Janet Mans, et al.

Biorxiv : the Preprint Server for Biology|January 30, 2023

Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2Yupeng Feng, Meng Yuan, John M Powers, et al.

JAMA Network Open|August 10, 2022

Durability of Heterologous and Homologous COVID-19 Vaccine BoostsC Sabrina Tan, Ai-Ris Y Collier, Jingyou Yu, et al.

Science Immunology|June 16, 2021

SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.

Science Translational Medicine|March 5, 2025

Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirusJuyeon Park, Lisa C Lindesmith, Adam S Olia, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026

Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V<sub>H</sub>1-2-rearranging mouse modelsHimanshu Batra, Sai Luo, Kevin O Saunders, et al.

Science Translational Medicine|May 10, 2023

Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccineYupeng Feng, Meng Yuan, John M Powers, et al.

Cell Reports|April 12, 2024

SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epitheliaRita M Meganck, Caitlin E Edwards, Michael L Mallory, et al.

Science Advances|March 27, 2026

One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine developmentNathan A Ona, Dapeng Zhang, Lisa C Lindesmith, et al.

Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:

Pageof 5

Cell Reports|October 20, 2023

Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Tyler D Gavitt, et al.

Emerging Infectious Diseases|December 8, 2023

Emergence of Novel Norovirus GII.4 VariantPreeti Chhabra, Damien C Tully, Janet Mans, et al.

Biorxiv : the Preprint Server for Biology|January 30, 2023

Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2Yupeng Feng, Meng Yuan, John M Powers, et al.

JAMA Network Open|August 10, 2022

Durability of Heterologous and Homologous COVID-19 Vaccine BoostsC Sabrina Tan, Ai-Ris Y Collier, Jingyou Yu, et al.

Science Immunology|June 16, 2021

SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.

Science Translational Medicine|March 5, 2025

Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirusJuyeon Park, Lisa C Lindesmith, Adam S Olia, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026

Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V<sub>H</sub>1-2-rearranging mouse modelsHimanshu Batra, Sai Luo, Kevin O Saunders, et al.

Science Translational Medicine|May 10, 2023

Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccineYupeng Feng, Meng Yuan, John M Powers, et al.

Cell Reports|April 12, 2024

SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epitheliaRita M Meganck, Caitlin E Edwards, Michael L Mallory, et al.

Science Advances|March 27, 2026

One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine developmentNathan A Ona, Dapeng Zhang, Lisa C Lindesmith, et al.

Pageof 5